Skip to main content
. 2016 Aug 4;3(2):e000428. doi: 10.1136/openhrt-2016-000428

Table 4.

Coronary haemodynamic variables

Variable, n (%) Placebo (n=11) Drug (n=11) p Value
Immediate post-PCI APV, cm/s 19 (9, 26) 30 (20, 37) 0.030*
Immediate post-PCI DSVR 1.7 (1.3, 3.5) 2 (1.4, 3.2) 0.93
CBF immediately after PCI, mL/min 53 (31, 94) 80 (43, 119) 0.19
CVR immediately after PCI, mm Hg/mL 2.1 (1, 2.6) 1.0 (0.8, 1.7) 0.15
Adenosine APV, cm/s 46 (34, 64) 56 (48, 72) 0.090
Adenosine DSVR 1.9±0.9 1.6±0.5 0.24
Post-adenosine CBF, mL/min 120 (84, 242) 127 (104, 313) 0.55
Post-adenosine CVR, mm Hg/mL 0.65 (0.38, 1.55) 0.59 (0.35, 0.8) 0.50
Max CFR 2.5 (1.8, 3) 2.1 (1.6, 2.9) 0.39

*p<0.05.

Data are expressed as median (IQR) or mean±SD.

APV, average peak velocity; CBF, coronary blood flow; CFR, coronary flow reserve; CVR, coronary vascular resistance; DSVR, diastolic/systolic velocity ratio.